Abstract
Primary intracranial sarcoma, DICER1-mutant, is a rare central nervous system tumor that predominantly affects children, only occasionally described in adults. We report on a 30-year-old man with a primary high-grade tumor initially diagnosed and treated as glioblastoma/gliosarcoma. Nineteen years later, re-evaluation by DNA methylation profiling together with next generation sequencing led to reclassification of the tumor as primary intracranial sarcoma, DICER1-mutant. Subsequent genetic testing confirmed a germline DICER1 mutation in both the patient and his son. Remarkably, radical resection of the tumor followed by external radiotherapy resulted in an unusually prolonged relapse-free survival, a course that appears unique among reported adult patients with DICER1-sarcoma. This report highlights the critical role of epigenomic profiling in CNS tumors exhibiting atypical clinical behavior, even decades after initial diagnosis, to achieve precise classification and optimize patient management. A brief review of DICER1-mutant sarcoma and DICER1 syndrome is also presented.
Get full access to this article
View all access options for this article.
